UBS Group AG - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 75 filers reported holding DESIGN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
UBS Group AG ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$42,631
-72.0%
18,064
-25.2%
0.00%
Q2 2023$152,221
+12702.4%
24,162
+11629.1%
0.00%
Q1 2023$1,189
-99.9%
206
-99.9%
0.00%
-100.0%
Q4 2022$1,600,837
+9905.2%
156,027
+15534.0%
0.00%
Q1 2022$16,000
+1500.0%
998
+2751.4%
0.00%
Q4 2021$1,000
-94.1%
35
-96.9%
0.00%
Q3 2021$17,000
+70.0%
1,134
+127.7%
0.00%
Q2 2021$10,000
+11.1%
498
+66.0%
0.00%
Q1 2021$9,0003000.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$15,402,4837.89%
Logos Global Management LP 5,032,501$11,876,7021.58%
Prosight Management, LP 1,203,745$2,840,8380.90%
TANG CAPITAL MANAGEMENT LLC 1,350,000$3,186,0000.45%
Soleus Capital Management, L.P. 1,025,000$2,419,0000.22%
RTW INVESTMENTS, LP 2,512,986$5,930,6470.12%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 180,000$425,0000.09%
Corton Capital Inc. 27,134$64,0360.03%
OCCUDO QUANTITATIVE STRATEGIES LP 100,722$237,7040.03%
Rock Springs Capital Management LP 460,391$1,086,5230.03%
View complete list of DESIGN THERAPEUTICS INC shareholders